194 related articles for article (PubMed ID: 16484713)
1. Targeted therapy with antineoplastons A10 and AS2-1 of high-grade, recurrent, and progressive brainstem glioma.
Burzynski SR; Janicki TJ; Weaver RA; Burzynski B
Integr Cancer Ther; 2006 Mar; 5(1):40-7. PubMed ID: 16484713
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival and complete response of a patient with recurrent diffuse intrinsic brain stem glioblastoma multiforme.
Burzynski SR; Lewy RI; Weaver R; Janicki T; Jurida G; Khan M; Larisma CB; Paszkowiak J; Szymkowski B
Integr Cancer Ther; 2004 Sep; 3(3):257-61. PubMed ID: 15312271
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary report.
Burzynski SR; Lewy RI; Weaver RA; Axler ML; Janicki TJ; Jurida GF; Paszkowiak JK; Szymkowski BG; Khan MI; Bestak M
Drugs R D; 2003; 4(2):91-101. PubMed ID: 12718563
[TBL] [Abstract][Full Text] [Related]
4. Main editor's comment to the paper: the response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma. Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek.
Di Rocco C
Childs Nerv Syst; 2014 Dec; 30(12):2063. PubMed ID: 25096071
[No Abstract] [Full Text] [Related]
5. The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma.
Burzynski SR; Janicki TJ; Burzynski GS; Marszalek A
Childs Nerv Syst; 2014 Dec; 30(12):2051-61. PubMed ID: 24718705
[TBL] [Abstract][Full Text] [Related]
6. Commentary: The response and survival of children with recurrent diffuse intrisic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, by Burzynski G, et al.
Massimino M; Clerici CA
Childs Nerv Syst; 2014 Dec; 30(12):2065-6. PubMed ID: 25079885
[No Abstract] [Full Text] [Related]
7. Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1.
Burzynski SR; Weaver RA; Janicki T; Szymkowski B; Jurida G; Khan M; Dolgopolov V
Integr Cancer Ther; 2005 Jun; 4(2):168-77. PubMed ID: 15911929
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report.
Burzynski SR; Weaver RA; Lewy RI; Janicki TJ; Jurida GF; Szymkowski BG; Khan MI; Bestak M
Drugs R D; 2004; 5(6):315-26. PubMed ID: 15563234
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma.
Buckner JC; Malkin MG; Reed E; Cascino TL; Reid JM; Ames MM; Tong WP; Lim S; Figg WD
Mayo Clin Proc; 1999 Feb; 74(2):137-45. PubMed ID: 10069350
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of antineoplastons A10 and AS2-1.
Burzynski SR
Mayo Clin Proc; 1999 Jun; 74(6):641-2. PubMed ID: 10377942
[No Abstract] [Full Text] [Related]
11. Complete response and long-term survival (>20 years) of a child with tectal glioma: a case report.
Burzynski SR; Burzynski GS; Janicki TJ; Marszalek A
Pediatr Neurosurg; 2015; 50(2):99-103. PubMed ID: 25926271
[TBL] [Abstract][Full Text] [Related]
12. Comment to the paper: The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma : Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek.
Blaskiewicz R
Childs Nerv Syst; 2014 Dec; 30(12):2067-8. PubMed ID: 25146834
[No Abstract] [Full Text] [Related]
13. Toxicological study on antineoplastons A-10 and AS2-1 in cancer patients.
Tsuda H; Hara H; Eriguchi N; Nishida H; Yoshida H; Kumabe T; Sugita Y
Kurume Med J; 1995; 42(4):241-9. PubMed ID: 8667595
[TBL] [Abstract][Full Text] [Related]
14. Comment to the paper "The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brain stem glioma" by Burzynski et al.
Wong TT
Childs Nerv Syst; 2014 Dec; 30(12):2069-70. PubMed ID: 25142686
[No Abstract] [Full Text] [Related]
15. Commentary on: "The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma." By Burzynski et al.
Perilongo G
Childs Nerv Syst; 2014 Dec; 30(12):2071-2. PubMed ID: 25330863
[TBL] [Abstract][Full Text] [Related]
16. Randomized phase II study of 5-fluorouracil hepatic arterial infusion with or without antineoplastons as an adjuvant therapy after hepatectomy for liver metastases from colorectal cancer.
Ogata Y; Matono K; Tsuda H; Ushijima M; Uchida S; Akagi Y; Shirouzu K
PLoS One; 2015; 10(3):e0120064. PubMed ID: 25790229
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.
Bouffet E; Jakacki R; Goldman S; Hargrave D; Hawkins C; Shroff M; Hukin J; Bartels U; Foreman N; Kellie S; Hilden J; Etzl M; Wilson B; Stephens D; Tabori U; Baruchel S
J Clin Oncol; 2012 Apr; 30(12):1358-63. PubMed ID: 22393086
[TBL] [Abstract][Full Text] [Related]
18. Temozolomide in the treatment of recurrent malignant glioma.
Chang SM; Theodosopoulos P; Lamborn K; Malec M; Rabbitt J; Page M; Prados MD
Cancer; 2004 Feb; 100(3):605-11. PubMed ID: 14745879
[TBL] [Abstract][Full Text] [Related]
19. Quick response of advanced cancer to chemoradiation therapy with antineoplastons.
Tsuda H; Sata M; Kumabe T; Hara H; Eriguchi N; Sugita Y; Nagamatsu H
Oncol Rep; 1998; 5(3):597-600. PubMed ID: 9538158
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma.
Reardon DA; Quinn JA; Vredenburgh J; Rich JN; Gururangan S; Badruddoja M; Herndon JE; Dowell JM; Friedman AH; Friedman HS
Cancer; 2005 Jan; 103(2):329-38. PubMed ID: 15558802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
